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Abstract: The purpose of this study was to compare the CUE Ovulation Predictor with the 
ovulation method in determining the fertile period. Eleven regularly ovulating women measured 
their salivary and vaginal electrical resistance (ER) with the CUE, observed their cervical-
vaginal mucus, and measured their urine for a luteinizing hormone (LH) surge on a daily basis. 
Data from 21 menstrual cycles showed no statistical difference (T = 0.33, P = 0.63) between the 
CUE fertile period, which ranged from 5 to 10 days (mean =6.7 days, SD =1.6), and the fertile 
period of the ovulation method, which ranged from 4 to 9 days (mean = 6.5 days, SO = 2.0). 
The CUE has potential as an adjunctive device in the learning and use of natural family planning 
methods. 
 
The ability to avoid or achieve pregnancy is important for regulating birth rates at the 
individual, family, and population levels. To help achieve this end, a number of technological 
devices have been and are being developed. These devices include electronic and 
computerized basal body temperature, hormonal test kits, cervical-vaginal fluid volume meters, 
and crystallization monitors (Fehring, 1991). Of these techniques, the most practical ones are 
those that are accurate, safe, and inexpensive and can be used at home for self-monitoring.  
A relatively new device that has been developed to aid in the prediction and detection of 
ovulation is the CUE Ovulation Predictor (Zetek Inc., Aurora, CO). The CUE consists of a 
handheld digital monitor with vaginal and oral sensors (see Fig. 1). The sensors detect and 
record the electrical resistance of salivary and vaginal secretions. The electrical resistance and 
ionic concentrations in both the saliva and vaginal-cervical secretions change in response to the 
cyclical changes in estrogen. The CUE Ovulation Predictor can be used to both predict and 
confirm ovulation. The peak value in salivary electrical resistance (SER) when using an oral 
probe occurs 5 to 7 days before ovulation, and the nadir, the lowest point of vaginal electrical 
resistance (VER) when using a vaginal probe, occurs approximately 1 day prior to ovulation. 
Use of the monitor requires daily morning measurements.  
Theoretically, the SER is an indirect measure of the estrogenic effects of the dominant 
follicle on adrenocorticotropic hormone (ACTH) and aldosterone levels (Fernando, Regas, & 
Betz, 1988a). As the dominant follicle develops in each menstrual cycle, the levels of ACTH and 
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aldosterone cause the increased production of NaCl. This increase in NaCl is reflected in 
salivary and vaginal secretions. The nadir in vaginal resistance occurs when the highest 
concentrations of NaCl are in the cervical mucus. This nadir is thought to coincide with 
ovulation. The lowest levels in NaCl production are reflected in the peak of SER which occurs 
about 5 to 7 days before ovulation. 
Over the last 10 years, a number of studies have been conducted to determine the 
usefulness and accuracy of the CUE Ovulation Predictor. These studies used either the 
luteinizing hormone (LH) surge in the urine or serum as a comparison marker of fertility. Most 
of the early studies on the CUE Ovulation Predictor emphasized its role in aiding infertility 
treatment and artificial insemination. Albrecht, Fernando, Regas, and Betz (1985) found in 18 
menstrual cycles from 13 women that the peak in LH occurred consistently 4 to 5 days after the 
peak measurement in SER and that the SER had a strong positive correlation (r = 0.94) to the 
LH surge. Fernando, Regas, and Betz (1988b) had similar findings with 23 women and 32 
menstrual cycles. They found the SER to be 5 to 7 days before the serum LH surge and that a 
strong positive correlation existed (r = 0.94) between the SER and the LH surge. Both Albrecht 
et al. (1985) and Fernando et al. (1988b) mentioned the potential use of the CUE for natural 
family planning (NFP).  
Moreno et al. (1988) conducted the first study to test the CUE Ovulation Predictor for its 
potential use in NFP. They analyzed 29 menstrual cycles from 11 women and found that the 
peak salivary resistance occurred 5 to 11 days before the estimated day of ovulation (i.e., 
estimated by the urine LH surge) in all 29 cycles. They noted that the VER nadir occurred 
within 2 days before the estimated day of ovulation in 93% of the cycles. The VER had a strong 
positive correlation (r = 0.79) with the estimated day of ovulation. The VER occurred after the 
estimated day of ovulation in only one cycle. Roumen and Dieben (1988), however, found no 
strong correlation between the CUE salivary peak and the day of the LH surge in 27 cycles 
measured among 18 female volunteers. Fernando and Betz (1988) disputed the results of the 
Roumen and Dieben study, claiming that the results had been misinterpreted and that the CUE 
Ovulation Predictor had not been used correctly. A final study by Jacobs, Blasco, and 
Sondheimer (1989) measured SER in 21 menstrual 
 
cycles with 21 female subjects. They did 
not use the CUE Ovulation Predictor, but rather the Peak Ovulation Predictor manufactured by 
Micron Medical Inc. (Boise, ID). They found that the SER occurred 4 to 9 days before the 
serum LH surge and that the SER had a moderate positive significant correlation (r = 0.61) with 
the serum LH surge.  
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Further clinical studies must be conducted on the CUE Ovulation Predictor to clarify its 
usefulness in determining the fertile period for achieving and/or avoiding pregnancy. No studies 
have been reported comparing the use of the CUE Ovulation Predictor with a modern method 
of NFP in determining the fertile period. The specific purpose of this study was to compare the 
CUE Ovulation Predictor with the self-observation of cervical-vaginal mucus using the 
Creighton model (CrM) ovulation method in determining the fertile time of the menstrual cycle. 
As in previous studies, the LH surge in the urine was used as a comparison marker of fertility. 
The terms that were used in this study are defined in Table 1.  
 
Methodology 
Study Design 
The design was descriptive comparative. Eleven women with regular menstrual cycles 
observed their cervical mucus, monitored their SER and VER, and measured their LH surge 
with a urine assay kit for two consecutive-cycles. Comparisons were made on the first day of 
fertility (as determined by the cervical mucus and the CUE SER peak) and on the estimated day 
of ovulation (as determined by the peak day of cervical mucus, the CUE VER nadir, and the 
urinary LH surge).  
Setting  
The 11 subjects were taught how to use the CUE Ovulation Predictor and the LH 
detection kit, and how to observe their cervical mucus by use of the CrM ovulation method in a 
conference room in a major university nursing center.  
Subjects 
The subjects for this study were 11 female clients selected (by phone or in person) from 
the 250 active female clients enrolled in the Marquette University Nursing Center NFP clinic. All 
11 of the subjects had menstrual cycles in the normal range of 26 to 35 days, had not been on 
oral, injectable, or subdermal contraceptives for at least 12 months, and had no known fertility 
problems. All of the subjects were taught how to monitor their menstrual cycles by daily 
observation of their cervical-vaginal mucus by the guidelines of the CrM ovulation method. The 
11 subjects ranged in age from 22 to 45 years (mean age 32); all were married and had used 
the CrM for 6 to 96 months (mean use 54 months). Table 2 lists the para and gravida for each 
subject.  
Data Measurement 
The urine LH surge was detected by use of the OvuQuick self-test kit (Quidel, Inc., San 
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Diego, CA). The OvuQuick is based on enzyme immunoassay of the LH monoclonal antibodies 
in the urine. The test has a reported LH sensitivity of 30 mlU/ml. OvuQuick has shown a 98% 
agreement with other tests in detecting the LH surge (Corson, Ghazi, & Kemmann, 1990). The 
detection of LH in the plasma or urine is considered by experts to be a standard method for 
predicting pending ovulation (Corson et aI., 1990; Fehring, 1990; Royston, 1991). This study 
used the 9-day test kits. A positive result is indicated when a spot activated on the test pad 
becomes as dark or darker than a reference spot.  
The peak day of cervical mucus was determined by means of the CrM vaginal discharge 
recording system (VDRS), developed through research conducted at St. Louis and Creighton 
University over a 5-year period (Hilgers, 1992; Hilgers, Daly, Hilgers, & Prebil, 1982). The 
recording system requires that women check for cervical mucus by wiping the outside of their 
vaginas (the vulvar area) every time they go to the bathroom to void and once before going to 
bed. The women check mucus for color, stretch, and consistency. Women use the VDRS to rate 
and chart their cervical mucus in a standardize way. The CrM through use of the VDRS has a 
reported 98.8% to 99% method effectiveness and a 95% to 98% use effectiveness for avoiding 
pregnancy (Doud, 1985; Fehring, Lawrence, & Philpot, 1994; Hilgers, 1991).  
The SER and VER recordings were made by using the CUE Ovulation Predictor 
described above. The CUE is a battery-operated device with a digital readout. Calibration of the 
monitor is in arbitrary units proportional to electrical resistance in ohms. The CUE oral and 
vaginal sensors were tested for accuracy according to the manufacturer's instructions.  
Procedure 
Once the 11 subjects had read and signed a university-approved consent form, they 
were given four LH ovulation prediction kits, a CUE Ovulation Predictor with salivary and vaginal 
probes, and two fertility charts. Each LH test kit provided enough material for the 9 days of 
testing. Subjects were asked to check their urine twice a day for the LH surge (once in the 
morning and once in the evening between 10:00 a.m. and 8:00 p.m.) and to record the results. 
They were also asked to measure their SER and VER once a day in the morning according to 
manufacturer's instructions and to conduct daily observations of their cervical-vaginal mucus. 
The results of the electrical recordings, LH detection, and cervical-vaginal observations were 
placed on fertility charts. Data analysis was accomplished by use of the SYSTAT computer 
software program (SYSTAT, Inc., Evanston, IL) to determine descriptive statistics and the 
Pearson product moment correlation coefficients among the LH surge, the SER, the VER, and 
the peak. The Student's t test was used to determine if there was a statistical difference in the 
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mean number of days of the fertile period as determined by the CUE and the CrM.  
 
Results 
Twenty-one of the 22 menstrual cycle charts were usable. One cycle was not included in 
the calculations because of missing data. All of the 21 cycles had a documented positive LH 
surge. Table 2 lists, by cycle and subject, the day of the LH surge, the VER, the SER, and the 
peak. In 20 out of 21 cycles (95% of the cycles), the peak day of cervical mucus and the VER 
nadir was within ± 3 days of the LH surge. Likewise, in 19 out of 21 cycles (90.5%), the peak 
day of cervical mucus was within ± 3 days of the VER. Table 3 shows the frequency and the 
percentage of the peak day and the VER nadir in relationship to the LH surge. Statistically, there 
was a strong positive correlation between the LH surge in the urine and the peak day of cervical 
mucus (r= 0.71, p < 0.01), between the LH surge and the VER nadir (r = 0.84, P < 0.01), 
between the LH surge and the SER peak (r = 0.79, p< 0.01), and between the peak and the 
VER nadir (r = 0.74, P < 0.01).  
The fertile period of the CrM as determined by the beginning of the mucus cycle and 
until 3 full days past the peak day of cervical mucus ranged from 4 to 10 days (mean 6.86, SD = 
2.13). The fertile period as measured by the CUE Ovulation Predictor was calculated from 2 
days after the SER peak until 3 days past the VER nadir. The CUE fertile period ranged from 3 
to 10 days (mean 6.57, SD = 1.43). There was no statistical difference (T= 0.474, p = 0.64) 
between the number of fertile days in each cycle as determined by the CUE Ovulation Predictor 
and the CrM ovulation method.  
 
Discussion 
The results of this study have relevance to a number of previous studies. Fehring (1990) 
showed that the peak day of cervical mucus coincided 95% of the time ± 3 days with the LH 
surge in the urine. Hilgers et al. (1978) also found in 64 cycles from 24 subjects that the peak in 
cervical mucus occurred 95% of the time ± 2 days with the estimated day of ovulation as 
determined by the LH surge in the serum. The higher percentage in the Hilgers et al. study 
might be due to the greater accuracy of the laboratory serum LH tests. The current study also 
found the peak day of cervical mucus to be ± 3 days within the LH surge 95% of the time, and 
that the VER nadir fell ± 3 days within the LH surge. The correlation of the SER with the LH 
surge (r = 0.79) in the current study was not quite as strong as the SER to LH peak correlation 
found in the Albrecht et al. (1985) study (r = 0.94) and the Fernando et al. (1988b) study (r = 
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0.94), but was stronger than that found in the Jacobs et al. (1989) study (r = 0.61). This variation 
in results might be due to whether urine or serum LH testing was used and to the different types 
of instruments used to measure electrical resistance.  
This study helps to confirm previous results on the accuracy of the CUE Ovulation 
Predictor in detecting fertility. Albrecht et al. (1985) found that the SER peak occurred 4 to 5 
days before the serum LH surge in 90% of the 21 cycles measured. Fernando et al. (1988b) 
found the SER peak to occur 5 to 7 days before the LH surge in all 32 menstrual cycles. Moreno 
et al. (1988) found that the SER peak occurred 5 to 11 days before the urine LH surge in 29 
cycles. The current study found the SER peak to be 3 to 7 days before the urine LH surge 
(100% of the time) in 21 cycles measured.  
The variation of the time of the SER peak to estimated time of ovulation in the above 
studies is probably due to the urine being less precise than the serum measure of LH. The LH in 
the urine does not "peak" as quickly (or as sharply) as the LH in the serum (i.e., the urine LH 
surge often occurred over 2 days). In the current study, the day of the LH surge was recorded 
as the last day that a positive reading was found. As a result, there is more variability in the data 
points. Why Roumen and Dieben (1988) did not find a strong correlation between the CUE SER 
peak and the estimated day of ovulation is not obvious. However, since they did not use the 
vaginal recordings, the reference points to determine the SER peak might not have been 
apparent.  
The lengths of the fertile period as determined by the CUE Ovulation Predictor and by 
the CrM ovulation method were similar (4 to 10 days for the CrM and 3 to 10 days for the CUE), 
as were the starting and end points. The Cue VER nadir and the CrM peak day are indirect 
measures of ovulation. The peak and the VER correlation was r = 0.74. The greatest difference 
between the CrM and the CUE was the markers for the beginning of the fertile period. The 
correlation between the beginning of the fertile period as determined by the CrM (which is the 
first day of the mucus cycle) and the SER peak was r = 0.65. The correlation between the 
beginning of the fertile period between the CrM and the "two day past the SER peak" guideline 
suggested by Moreno et al. (1988) for use of the CUE in NFP was also r = 0.65. Some of the 
variability was due to short or limited mucus cycles, long mucus cycles due to continuous 
mucus, and unexplained short and long CUE SER peak to LH surge ratios. The short SER peak 
to LH surge (i.e., the estimated day of ovulation) could be a problem if this device is being used 
as a means to prevent pregnancy, as it has been estimated that sperm can live 3 to 5 days in 
good cervical mucus. The 3-day prediction period given in some of the CUE cycles would not be 
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long enough to prevent pregnancy.  
The conclusion of this research is that the CUE Ovulation Predictor and the CrM are 
similar in their ability to predict the fertile period of the female's menstrual cycle. Both the CUE 
Ovulation Predictor and the CrM have some degree of variation in predicting and detecting 
ovulation. The greatest variation is in the ability to predict the beginning of the fertile period. A 
caution of this conclusion is that it is based only on a small number of menstrual cycles and 
subjects. Further research needs to be conducted on the CUE Ovulation Predictor for its 
potential use in NFP. Although the LH surge is an accepted method for determining optimal time 
of fertility, the use of a more precise marker (such as serial abdominal and/or vaginal ultrasound 
to track follicular development) would be recommended. This, however, would take a 
considerable amount of time and money for the subjects and investigators. Another area of 
research would be to conduct a prospective use-effectiveness study on subjects trying to avoid 
and achieve pregnancy using the CrM ovulation method and the CUE Ovulation Predictor 
simultaneously. Comparisons could then be made on the respective days of the fertile period 
and the timing of intercourse.  
One deficit of the CUE Ovulation Predictor is that it requires an invasive vaginal probe. 
An objective external marker for ovulation would be better. The CUE, like the ovulation method, 
has some variation in results when there is continuous mucus due to vaginal infection or vaginal 
irritation. The CUE Ovulation Predictor also only gives limited knowledge of the menstrual cycle. 
Women who use the monitor would not be able to determine the quality of their mucus and 
possible problems such as unusual bleeding and vaginal and cervical infections as readily as 
would women who use the ovulation method.  
At the present time the CUE has potential as an adjunctive device in the learning and 
use of the ovulation method of family planning. The CUE Ovulation Predictor could provide 
women who use the ovulation method with another objective marker to confirm their own 
observations. The CUE could also be used as a tool by an advanced practice nurse (e.g., 
certified nurse midwife [CNM], adult nurse practitioner [ANP], OB/GYN) specializing in women's 
health care. At this time the CUE should be used only as an adjunctive device with the guidance 
of competent practitioners who are knowledgeable about the recommended protocols of the 
CUE Ovulation Predictor.  
 
Notes 
• Address correspondence to Richard J. Fehring, DNSc, RN, CNFPP, Associate Professor 
and Coordinator-Advanced Practice Nursing: Adult, Marquette University, College of 
8  Fehring 
 
Nursing, Emory T. Clark Hall, P. O. Box 1881, Milwaukee, WI 53201-1881.  
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College of Nursing Milwaukee, Wisconsin  
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Appendix 
Table 1  
Definition of Terms 
Salivary electrical resistance peak (SER) -the first high value of the CUE Ovulation Predictor 
when using the oral probe occurring on or after the start day of measurement followed 
by 2 days of lower readings. The SER occurs about 5 to 11 days before ovulation.  
 
Luteinizing hormone (LH) surge -the highest level of LH after the beginning of the menstrual 
cycle as determined by a positive reading on a urine assay test kit. The LH surge occurs 
in the urine about 12 to 24 hours before ovulation (Corson, 1986; Seibel, 1986).  
 
Vaginal electrical resistance nadir (VER) -the lowest reading on the CUE Ovulation Predictor 
when using the vaginal probe to detect electrical resistance readings.  
 
The peak day of cervical-vaginal mucus (peak) -the last day of observable mucus in the 
woman's menstrual cycle that is either clear, stretches more than an inch, and/or has a 
lubricative sensation.  
 
Regular menstrual cycle -a cycle that ranges from 26 to 35 days in length in women who have 
no known fertility problems.  
 
The fertile period -defined by the Creighton model (CrM) ovulation method as the beginning of 
the observable cervical mucus (the mucus cycle) until 3 full days past the peak. The 
fertile period as measured by the CUE Ovulation Predictor was calculated from 2 days 
after the SER until 3 full days past the VER.  
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Table 2 
Comparison of the Luteinizing Hormone (LH) Surge with the Salivary Electrical 
Resistance (SER) Peak and the Vaginal Electrical Resistance nadier (VER) 
Subject 
No. 
Age 
(years) 
P/G LH-1 Peak-1 VER-1 LH-2 Peak -2 VER-2 
1 31 2/2 17 18 17 - - - 
2 25 0/0 18 19 20 18 18 20 
3 31 2/2 17 18 17 14 17 14 
4 40 4/2 15 16 13 16 19 14 
5 33 4/4 12 12 12 13 14 11 
6 30 4/4 15 12 12 13 11 9 
7 22 0/0 14 14 15 20 19 18 
8 22 0/0 15 13 12 18 13 18 
9 45 6/5 13 15 14 14 16 13 
10 36 2/2 16 16 17 20 21 22 
11 38 2/2 15 16 18 16 17 16 
Note. PIG = para/gravida; LH-1, Peak-1, VER-1, LH-2, Peak-2, VER-2 = day of the LH surge, peak day of 
cervical mucus, and the vaginal electrical resistance nadir of the first and second menstrual cycles, 
respectively.  
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Table 3 
Relationship of the Luteinizing Hormone (LH) Surge with the Salivary Electrical 
Resistance (SER) Peak and the Vaginal Electrical Resistance Nadir (VER) 
 LH-3a LH-2a LH-1a LH LH+1b LH+2b LH+3b 
No of peak days 1 0 1 4 8 4 2 
% of peak days 4.8 0 4.8 19.1 38.0 19.0 9.5 
No. of VER nadirs 2 4 1 6 3 2 2 
% of VER nadirs 9.5 19.0 4.8 28.6 14.3 9.5 9.5 
aThe minus sign (-) indicates days before the LH surge. 
bThe plus sign (+) indicates days after the LH surge. 
 
Figure 1 
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